The results showed that α-NETA and α-NETA plus PD98059 improved hepatic steatosis but no impact on TNF-α level of liver homogenates, infers that there was no influence on the progression of steatosis to steatohepatitis. The gene discussed is TNF; the disease is fatty liver disease.